Advanced search
Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Email Registration
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
  1. Homepage
  2. Equities
  3. United States
  4. Nyse
  5. Johnson & Johnson
  6. News
  7. Summary
    JNJ   US4781601046

JOHNSON & JOHNSON

(JNJ)
  Report
Real-time Estimate Cboe BZX  -  07:59:15 2023-06-08 pm EDT
160.70 USD   +0.27%
09:29aJohnson & Johnson Releases its 2022 Health for Humanity Report and We All Belong, 2022 DEI Impact Review
AQ
09:12aJohnson & Johnson Releases 2022 Health for Humanity Report Demonstrating Progress Against Goals
AQ
03:55aJohnson & Johnson Health Care Systems Gets Up to $47.3 Million US Defense Logistics Agency Contract
MT
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
 SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies
Most relevant news about JOHNSON & JOHNSON
09:29aJohnson & Johnson Releases its 2022 Health for Humanity Report and We All Belong, 2022 ..
AQ
09:12aJohnson & Johnson Releases 2022 Health for Humanity Report Demonstrating Progress Again..
AQ
03:55aJohnson & Johnson Health Care Systems Gets Up to $47.3 Million US Defense Logistics Age..
MT
06/07Johnson & Johnson : Janssen Submits Supplemental Biologics License Application to U.S. FDA..
PU
06/07Janssen Submits Supplemental Biologics License Application to U.S. FDA Seeking Approval..
AQ
06/06Johnson & Johnson to Host Investor Conference Call on Second-Quarter Results
BU
06/06Johnson & Johnson Submits Supplemental Biologics License Application to U.S. FDA Seekin..
CI
06/06Advancing Multiple Shots On Clinical Goals, Coeptis Therapeutics Positions For A Busy V..
AQ
06/05Johnson & Johnson : CARVYKTI® (ciltacabtagene autoleucel) Reduces Risk of Disease Progress..
PU
06/05Johnson & Johnson Announces Long-Term Data from the Pivotal Phase 1/2 Majestec-1 Study
CI
06/05The Janssen Pharmaceutical Companies of Johnson & Johnson Announces Results from the Ph..
CI
06/05Johnson & Johnson Unit Recalls Impella Heart Pump, US FDA Designates Class 1 Recall Ord..
MT
06/05Johnson & Johnson : Janssen Presents Longer-Term Data for TECVAYLI® (teclistamab-cqyv) Sho..
PU
06/05Johnson & Johnson : Janssen Presents First-Ever Results from Dual Bispecific Combination S..
PU
06/05Janssen Pharmaceutical - New Long-Term Data from the CHRYSALIS Study Show Median Progre..
AQ
More most relevant news
All news about JOHNSON & JOHNSON
09:29aJohnson & Johnson Releases its 2022 Health for Humanity Report and We All Belong, 2022 ..
AQ
09:12aJohnson & Johnson Releases 2022 Health for Humanity Report Demonstrating Progress Again..
AQ
03:55aJohnson & Johnson Health Care Systems Gets Up to $47.3 Million US Defense Logistics Age..
MT
06/07Johnson & Johnson : Janssen Submits Supplemental Biologics License Application to U.S. FDA..
PU
06/07Indices: Flight to quality
MS
06/07Janssen Submits Supplemental Biologics License Application to U.S. FDA Seeking Approval..
AQ
06/06Johnson & Johnson to Host Investor Conference Call on Second-Quarter Results
BU
06/06Johnson & Johnson Submits Supplemental Biologics License Application to U.S. FDA Seekin..
CI
06/06Alkermes Gets Final Award in Janssen Pharmaceutica Arbitration; 2023 Adjusted EPS, Reve..
MT
06/06Advancing Multiple Shots On Clinical Goals, Coeptis Therapeutics Positions For A Busy V..
AQ
More news
News in other languages on JOHNSON & JOHNSON
03:55aJohnson & Johnson Health Care Systems obtient un contrat de 47,3 millions de dollars de..
06/06Johnson & Johnson soumet à la FDA une demande d'autorisation de mise sur le marché supp..
06/06Indizes: Fly to quality
06/06J&J : des résultats prometteurs pour Carvykti
06/06Alkermes reçoit la sentence finale dans l'arbitrage de Janssen Pharmaceutica ; révision..
06/06J&J : présente des données à plus long terme sur Tecvayli
06/06J&J : résultats encourageants pour le Balversa
06/06Indices : Fly to quality avec une fusée
06/05Rubrik, soutenue par Microsoft, engage des banques pour son introduction en bourse -sou..
06/05Johnson & Johnson annonce les données à long terme de l'étude pivotale de phase 1/2 Maj..
More news
Analyst Recommendations on JOHNSON & JOHNSON
05/30Kenvue Initiated at Outperform by RBC, Price Target Set at $29 as Firm Highlights Johns..
MT
04/20UBS Adjusts Johnson & Johnson Price Target to $177 From $164, Maintains Neutral Rating
MT
04/19Atlantic Equities Trims Price Target on Johnson & Johnson to $167 From $168, Keeps Neut..
MT
04/19Bernstein Adjusts Price Target on Johnson & Johnson to $176 From $173, Keeps Market Per..
MT
04/19Raymond James Adjusts Price Target on Johnson & Johnson to $181 From $185, Keeps Outper..
MT
More recommendations
Press releases
09:29aJohnson & Johnson Releases its 2022 Health for Humanity Report and We All Belong, 2022 ..
AQ
09:12aJohnson & Johnson Releases 2022 Health for Humanity Report Demonstrating Progress Again..
AQ
06/07Johnson & Johnson : Janssen Submits Supplemental Biologics License Application to U.S. FDA..
PU
06/07Janssen Submits Supplemental Biologics License Application to U.S. FDA Seeking Approval..
AQ
06/06Johnson & Johnson to Host Investor Conference Call on Second-Quarter Results
BU
More press releases
Analysis
All about credit ratings
Official Publications
05/03SEC Filing 8K 
04/28SEC Filing 10Q-1 
04/27Minutes of the general assembly 
04/18SEC Filing 8K 
04/181st quarter results 
04/04SEC Filing 8K 
Upcoming event on JOHNSON & JOHNSON
06/13/23Goldman Sachs Global Healthcare Conference
Upcoming sector events
07/27/23ROCHE HOLDING AG : Q2 2023 Earnings Release
08/01/23MERCK & CO. : Q2 2023 Earnings Release
08/08/23ELI LILLY AND COMPANY : Q2 2023 Earnings Release
08/10/23NOVO NORDISK A/S : Q2 2023 Earnings Release
Sector
Healthcare
Pharmaceuticals & Medical Research
 Pharmaceuticals
  Pharmaceuticals
   Other Pharmaceuticals
Secure and increase the performance of your investments with our team of experts at your side.
Securing my Investments
fermer